Connection

Adam Brufsky to Health Expenditures

Back to Details
This is a "connection" page, showing publications Adam Brufsky has written about Health Expenditures.
Adam Brufsky
Connection Strength
0.028
Health Expenditures
  1. Cost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States. J Med Econ. 2020 Jan; 23(1):37-47.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.